1. Home
  2. /
  3. Investments
  4. /
  5. Prothea Technologies

Prothea Technologies

Prothea Technologies, founded in 2021, is a private medical technology company developing a bronchoscope device for the biopsy and treatment of lung cancer in a single hospital visit.
The company is developing a medical device combining a microendoscope and an image processing system enabling enhanced visualisation and in situ analysis of lesion structure at a molecular level, as well as a laser ablation catheter to enable treatment immediately following visualisation and biopsy.

Team

Venture Capital

Status

Current

Geography

Europe

Financing Round

Minority

Segment

Life Science Tools, MedTech & Diagnostics

Entry Date

2024

Key Figures

Current

Status

2021

Creation Date

10

Number of Employees

2024

Investment Date

OMX Europe Venture Fund

Fund Name

Key Contacts

Related companies